Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00146744
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2005-09-06
Brief Title:
Safety and Immunogenicity of GSK Biologicals Candidate Tuberculosis Vaccine Mtb72FAS02A in Healthy PPD-positive Adults
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-07
Start Date Type:
None
Primary Completion Date:
2006-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-06
First Submit QC Date:
September 6 2005
Study First Post Date:
2005-09-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-24
Last Update Post Date:
2017-05-30
Last Update Post Date Type:
ACTUAL